Sunesis Pharmaceuticals to Report Financial Results for the First Quarter on May 8, 2008

SOUTH SAN FRANCISCO, Calif., April 30  /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule therapeutics, today announced that management will hold an investor conference call on Thursday, May 8, 2008 at 11:00 a.m. ET/8:00 a.m. PT to discuss financial results for the first quarter ended March 31, 2008.

Individual and institutional investors can access the call via [phone] (U.S. and Canada) or [phone] (international).  To access the live audio webcast or the subsequent archived recording, visit the "Investors and Media -- Calendar of Events" section of the Sunesis website at http://www.sunesis.com/.  Please log on to Sunesis' website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases.  Sunesis has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics.  Sunesis is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies.  For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com/. 

DATASOURCE: Sunesis Pharmaceuticals, Inc.



CONTACT:  Investors, Eric Bjerkholt, SVP, Corp. Development & Finance of

Sunesis Pharmaceuticals, Inc., [phone]; or Media, Karen L. Bergman, or

Michelle Corral, both of BCC Partners, [phone], or [phone],

both for Sunesis Pharmaceuticals, Inc.



Web site:  http://www.sunesis.com/ 

Copyright